Meeting
2024 ASCO Genitourinary Cancers Symposium
Impact of insurance payer status (IS) on practice patterns and overall survival (OS) in patients (pts) with metastatic urothelial carcinoma (mUC).
Authors
Benjamin D. Mercier
City of Hope Comprehensive Cancer Center, Duarte, CA
Benjamin D. Mercier , Nishita Tripathi , Ameish Govindarajan , Georges Gebrael , Arshit Narang , Xiaochen Li , Daniela V. Castro , Alex Chehrazi-Raffle , Nazli Dizman , Hedyeh Ebrahimi , Neal Shiv Chawla , Joann Hsu , Cristiane Decat Bergerot , Regina Barragan-Carrillo , Zeynep Busra Zengin , Luis A Meza , Sumanta Kumar Pal , Neeraj Agarwal , Abhishek Tripathi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 547)
DOI
10.1200/JCO.2024.42.4_suppl.547
Abstract #
547
Poster Bd #
D18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
HCRN GU14-188: Phase Ib/II study of neoadjuvant pembrolizumab and chemotherapy for T2-4aN0M0 urothelial cancer.
First Author: Jason Brown
Poster
2018 Gastrointestinal Cancers Symposium
The effect of socioeconomic factors on the outcome of hepatocellular carcinoma.
First Author: Cortlandt Sellers
Poster
2018 Gastrointestinal Cancers Symposium
The effect of socioeconomic factors on the outcome of intrahepatic cholangiocarcinoma.
First Author: Cortlandt Sellers
Poster
2018 Gastrointestinal Cancers Symposium
Impact of insurance status on survival in neuroendocrine tumors: A multi-institutional Study from the U.S. Neuroendocrine Study Group.
First Author: Paula Marincola Smith